The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Plasma miR371 for the detection of viable germ cell tumor in testicular cancer patients with enlarging or post chemotherapy residual nodes.
 
Lucia Nappi
Honoraria - Pfizer
Speakers' Bureau - Pfizer
 
Marisa Thi
No Relationships to Disclose
 
Bernhard J. Eigl
Honoraria - Janssen; Pfizer
Consulting or Advisory Role - AstraZeneca; Merck; Roche Canada
Speakers' Bureau - Merck
Travel, Accommodations, Expenses - AstraZeneca; Janssen
 
Kim N. Chi
Honoraria - Amgen; Astellas Pharma; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi
Research Funding - Amgen (Inst); Astellas Pharma (Inst); Bayer (Inst); Janssen (Inst); Lilly/ImClone (Inst); Novartis (Inst); Oncogenex (Inst); Sanofi (Inst); Teva (Inst); Tokai Pharmaceuticals (Inst)
 
Martin Gleave
Stock and Other Ownership Interests - OncoGenex
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen; Oncogenex; Sanofi
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen; Oncogenex; Sanofi
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427
 
Alan I. So
Honoraria - Amgen; Astellas Oncology; Janssen
Speakers' Bureau - Amgen; Astellas Oncology; Janssen
 
Daniel Khalaf
No Relationships to Disclose
 
Peter C. Black
Consulting or Advisory Role - Abbvie; Allergan; Amgen; Astellas Pharma; Bayer; BioCancell; Biosyent; Cubist; Ferring; Janssen Oncology; Lilly; MDxHealth; Merck; Novartis; Roche Canada; Sanofi; Sitka; Spectrum Pharmaceuticals
Speakers' Bureau - Ferring; Red Leaf Medical
Research Funding - GenomeDx; iProgen; New B Innovation
Patents, Royalties, Other Intellectual Property - 1. PCT/CA2014/000787. Canada. 2014-11-03 Cancer Biomarkers and Classifiers and uses thereof. 2. #61899648 United States. 2013-03-13 Bladder cancer signature.
Travel, Accommodations, Expenses - Bayer; Janssen; Sanofi
 
Craig R. Nichols
Research Funding - Intermountain Precision Genomics (Inst)
Travel, Accommodations, Expenses - Seagen
 
Christian K. Kollmannsberger
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Novartis; Pfizer; Seagen
Travel, Accommodations, Expenses - Novartis; Pfizer